Published in Rev Rhum Mal Osteoartic on April 01, 1983
Essential Bacillus subtilis genes. Proc Natl Acad Sci U S A (2003) 14.01
Acetate utilization and macromolecular synthesis during sporulation of yeast. J Bacteriol (1969) 5.73
Nicotine metabolism and intake in black and white smokers. JAMA (1998) 5.03
Smokers of low-yield cigarettes do not consume less nicotine. N Engl J Med (1983) 4.80
Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. J Chromatogr (1981) 3.72
Crystal structure of transcription factor E47: E-box recognition by a basic region helix-loop-helix dimer. Genes Dev (1994) 3.30
Cotinine disposition and effects. Clin Pharmacol Ther (1983) 3.26
The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol (1999) 3.22
Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin Pharmacol Ther (1988) 3.05
Conditional mutants of meiosis in yeast. J Bacteriol (1970) 2.93
Influence of smoking fewer cigarettes on exposure to tar, nicotine, and carbon monoxide. N Engl J Med (1986) 2.87
Bacillus subtilis genome project: cloning and sequencing of the 97 kb region from 325 degrees to 333 degrees. Mol Microbiol (1993) 2.49
Daily intake of nicotine during cigarette smoking. Clin Pharmacol Ther (1984) 2.43
Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther (1994) 2.41
The sacT gene regulating the sacPA operon in Bacillus subtilis shares strong homology with transcriptional antiterminators. J Bacteriol (1990) 2.40
Dose-responses from multi-model inference for the non-cancer disease mortality of atomic bomb survivors. Radiat Environ Biophys (2012) 2.31
Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers. Clin Pharmacol Ther (1993) 2.30
Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther (1994) 2.28
Cotinine in the serum, saliva, and urine of nonsmokers, passive smokers, and active smokers. Am J Public Health (1988) 2.16
The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy. J Med Genet (1992) 2.15
Ethnic differences in N-glucuronidation of nicotine and cotinine. J Pharmacol Exp Ther (1999) 2.14
Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther (1982) 2.12
Association of the amino-terminal half of c-Src with focal adhesions alters their properties and is regulated by phosphorylation of tyrosine 527. EMBO J (1994) 2.08
PRD--a protein domain involved in PTS-dependent induction and carbon catabolite repression of catabolic operons in bacteria. Mol Microbiol (1998) 2.08
Role of bkdR, a transcriptional activator of the sigL-dependent isoleucine and valine degradation pathway in Bacillus subtilis. J Bacteriol (1999) 1.94
Spatial distribution of Eucalyptus roots in a deep sandy soil in the Congo: relationships with the ability of the stand to take up water and nutrients. Tree Physiol (2001) 1.77
Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines. Eur J Pharmacol (1999) 1.73
Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy. J Clin Oncol (1997) 1.67
Prospective multicenter evaluation of colon capsule examination indicated by colonoscopy failure or anesthesia contraindication. Endoscopy (2012) 1.63
Circadian blood nicotine concentrations during cigarette smoking. Clin Pharmacol Ther (1982) 1.60
Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/benzoylecgonine concentrations. J Clin Psychopharmacol (1993) 1.60
Novel phosphotransferase system genes revealed by genome analysis - the complete complement of PTS proteins encoded within the genome of Bacillus subtilis. Microbiology (1999) 1.59
Bacillus subtilis sucrose-specific enzyme II of the phosphotransferase system: expression in Escherichia coli and homology to enzymes II from enteric bacteria. Proc Natl Acad Sci U S A (1987) 1.56
Preliminary observations on the effects of age on oropharyngeal deglutition. Dysphagia (1989) 1.53
Adequacy of "hot biopsy" for the treatment of diminutive polyps: a prospective randomized trial. Am J Gastroenterol (1989) 1.49
Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactions. Ann Intern Med (1989) 1.48
Reduced tar, nicotine, and carbon monoxide exposure while smoking ultralow- but not low-yield cigarettes. JAMA (1986) 1.45
Determinants of nicotine intake while chewing nicotine polacrilex gum. Clin Pharmacol Ther (1987) 1.45
Deficient C-oxidation of nicotine. Clin Pharmacol Ther (1995) 1.43
[RNA polymerases in the uterine endometrium of heifers. Stimulation of nucleolar RNA polymerase by the cytoplasmic 5 S-estradiol complex]. C R Acad Sci Hebd Seances Acad Sci D (1971) 1.39
Methamphetamine and ethanol interactions in humans. Clin Pharmacol Ther (1995) 1.28
Nicotine metabolism and elimination kinetics in newborns. Clin Pharmacol Ther (2000) 1.26
A reordering of human chromosome 19 long-arm DNA markers and identification of markers flanking the myotonic dystrophy locus. Genomics (1989) 1.24
Bioavailability of sublingual buprenorphine. J Clin Pharmacol (1997) 1.21
Post-Chornobyl thyroid cancers in Ukraine. Report 1: estimation of thyroid doses. Radiat Res (2005) 1.20
Trans-3'-hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smoking. Br J Clin Pharmacol (2001) 1.17
Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking. Br J Clin Pharmacol (1997) 1.17
Effects of cigarette smoking and its cessation on lipid metabolism and energy expenditure in heavy smokers. J Clin Invest (1994) 1.16
Fluoroquinolone induced tendinopathy: report of 6 cases. J Rheumatol (1996) 1.16
Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis. Ann Rheum Dis (2001) 1.15
Internal exposure from the ingestion of foods contaminated by 137Cs after the Chernobyl accident--report 2. Ingestion doses of the rural population of Ukraine up to 12 y after the accident (1986-1997). Health Phys (2000) 1.14
Daily use of smokeless tobacco: systemic effects. Ann Intern Med (1989) 1.13
Influence of nicotine on cardiovascular and hormonal effects of cigarette smoking. Clin Pharmacol Ther (1984) 1.11
Comparison of EPR occupational lifetime external dose assessments for Mayak nuclear workers and film badge dose data. Radiat Environ Biophys (2006) 1.11
Nicotine and carbon monoxide intake from high- and low-yield cigarettes. Clin Pharmacol Ther (1984) 1.10
Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine. J Pharmacol Exp Ther (1998) 1.10
Incidence of Guillain-Barré syndrome in Ontario and Quebec, 1983-1989, using hospital service databases. Epidemiology (1994) 1.10
Stable isotope studies of nicotine kinetics and bioavailability. Clin Pharmacol Ther (1991) 1.09
Cryoglobulinemic neuropathy: a pathological study. Ann Neurol (1980) 1.07
Time trends of thyroid cancer incidence in Belarus after the Chernobyl accident. Radiat Res (1999) 1.06
Disposition kinetics and effects of intravenous nicotine. Clin Pharmacol Ther (1980) 1.06
A yeast two-hybrid study of human p97/Gab2 interactions with its SH2 domain-containing binding partners. FEBS Lett (2001) 1.06
Radiation doses from Ural region. Nature (1996) 1.06
Tick-bite meningoradiculoneuritis: clinical, electrophysiologic, and histologic findings in 10 cases. Neurology (1987) 1.06
Nicotine dependence and tolerance in man: pharmacokinetic and pharmacodynamic investigations. Prog Brain Res (1989) 1.06
Visual cognition: a new look at the two-visual systems model. Neuropsychologia (2005) 1.05
Intravenous nicotine replacement suppresses nicotine intake from cigarette smoking. J Pharmacol Exp Ther (1990) 1.04
Expression of a new operon from Bacillus subtilis, ykzB-ykoL, under the control of the TnrA and PhoP-phoR global regulators. J Bacteriol (2000) 1.04
Disposition kinetics and effects of menthol. Clin Pharmacol Ther (1999) 1.03
Metabolism of nicotine by human liver microsomes: stereoselective formation of trans-nicotine N'-oxide. Chem Res Toxicol (1992) 1.03
Verification of external exposure assessment for the upper Techa riverside by luminescence measurements and Monte Carlo photon transport modeling. Radiat Environ Biophys (2003) 1.03
Blood cotinine levels as indicators of smoking treatment outcome. Clin Pharmacol Ther (1984) 1.02
Effects of cigarette smoking and carbon monoxide on nicotine and cotinine metabolism. Clin Pharmacol Ther (2000) 1.01
Sympathomimetic effects of paraxanthine and caffeine in humans. Clin Pharmacol Ther (1995) 0.99
Investigations of thermoluminescence dosimetry in the Techa river flood plain: analysis of the new results. Radiat Prot Dosimetry (2002) 0.99
Issues in the reconstruction of environmental doses on the basis of thermoluminescence measurements in the Techa riverside. Health Phys (1998) 0.98
Releasable suture technique for trabeculectomy. Indian J Ophthalmol (1997) 0.98
Important factors governing exposure of the population and countermeasure application in rural settlements of the Russian Federation in the long-term after the Chernobyl accident. J Environ Radioact (2001) 0.97
Characterization of the precursor form of the exocellular levansucrase from Bacillus subtilis. Biochem Biophys Res Commun (1984) 0.97
Cardiovascular effects of carbon monoxide and cigarette smoking. J Am Coll Cardiol (2001) 0.97
Mechanistic modelling in large case-control studies of lung cancer risk from smoking. Stat Med (2002) 0.96
Decrease in the size of the myotonic dystrophy CTG repeat during transmission from parent to child: implications for genetic counselling and genetic anticipation. Am J Med Genet (1993) 0.96
Depth-dose distribution in bricks determined by thermoluminescence and by Monte-Carlo calculation for external gamma-dose reconstruction. Appl Radiat Isot (1996) 0.96
Dose-related cardiovascular and endocrine effects of transdermal nicotine. Clin Pharmacol Ther (1998) 0.96
Studies on the Mayak nuclear workers: dosimetry. Radiat Environ Biophys (2002) 0.95
First international intercomparison of luminescence techniques using samples from the Techa River Valley. Health Phys (2002) 0.95
Airway obstruction and rheumatoid arthritis. Eur Respir J (1997) 0.95
Ophthalmoplegic migraine: inflammatory neuropathy with secondary migraine? Can J Neurol Sci (2007) 0.95
Miller-Dieker syndrome. Detection of a cryptic chromosome translocation using in situ hybridization in a family with multiple affected offspring. Am J Dis Child (1993) 0.94
Sacroiliitis with Salmonella typhimurium--one case. J Rheumatol (1984) 0.94
Nicotine renal excretion rate influences nicotine intake during cigarette smoking. J Pharmacol Exp Ther (1985) 0.94
Breast cancer risk in atomic bomb survivors from multi-model inference with incidence data 1958-1998. Radiat Environ Biophys (2011) 0.94
Photon dose conversion coefficients for human teeth in standard irradiation geometries. Health Phys (2005) 0.94
Highly specific anti-estradiol antibodies: structural characterisation and binding diversity. J Mol Biol (2002) 0.93
Thyroid cancer risk to children calculated. Nature (1998) 0.93
Stochastic aspects and uncertainties in the prechemical and chemical stages of electron tracks in liquid water: a quantitative analysis based on Monte Carlo simulations. Radiat Environ Biophys (2000) 0.92
[Arthritis caused by Yersinia enterocolitica with the presence of intra-articular germs]. Rev Rhum Mal Osteoartic (1986) 0.92
Saliva cotinine levels as a function of collection method. Addiction (1997) 0.92